2020
Using a Collaborative, Virtual Discussion Platform to Mobilize Oncologic Expertise for the COVID-19 Pandemic.
Bejjani A, Burt L, Washington C, Terao M, Housri S, Housri N. Using a Collaborative, Virtual Discussion Platform to Mobilize Oncologic Expertise for the COVID-19 Pandemic. JCO Clinical Cancer Informatics 2020, 4: 794-798. PMID: 32897736, PMCID: PMC7529517, DOI: 10.1200/cci.20.00073.Peer-Reviewed Original ResearchConceptsGynecologic oncologyPediatric oncologyActive disease sitesCOVID-19 pandemicOncology patientsMedical oncologyClinical managementBreast cancerOncology expertsCare resourcesInitial experienceDisease sitesDisease typeOncologyWorldwide pandemicOncologistsRadiation oncologyHealth careCOVID-19Peer-reviewed informationSubstantial numberPandemicTotal numberPatientsCancer
2017
Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice
Rosenberg SA, Baschnagel AM, Bagley SJ, Housri N. Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice. Current Oncology Reports 2017, 19: 5. PMID: 28168606, DOI: 10.1007/s11912-017-0563-z.Peer-Reviewed Original ResearchConceptsStereotactic body radiotherapyNon-small cell lung cancer (NSCLC) treatmentCell lung cancer treatmentLung cancer treatmentNational clinical trialEvidence-based treatmentsEvidence-based medicineTranslating EvidenceCommunity oncologistsBody radiotherapyLung cancerClinical trialsPreclinical discoveryClinical practiceCommunity settingsCancer treatmentOncologistsCommunity practiceTreatmentMedicineImmunotherapyNSCLCInternet-based resourcesRadiotherapyCancer
2014
Significance of Phospho(Ser73)-K8 Expression in Women With Breast Cancer of Triple Negative Phenotype
Garg R, Housri N, Kongara S, Wu H, Schiff D, Moran M, Karantza V, Haffty B. Significance of Phospho(Ser73)-K8 Expression in Women With Breast Cancer of Triple Negative Phenotype. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s69-s70. DOI: 10.1016/j.ijrobp.2014.05.230.Peer-Reviewed Original Research
2013
Non-White Women Are as Likely as White Women to Receive Hypofractionated Radiation Therapy for Breast Cancer, But Less Likely to Enroll in Hypofractionation Clinical Trials
Housri N, Khan A, Taunk N, Nelson C, Goyal S, Haffty B. Non-White Women Are as Likely as White Women to Receive Hypofractionated Radiation Therapy for Breast Cancer, But Less Likely to Enroll in Hypofractionation Clinical Trials. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s491. DOI: 10.1016/j.ijrobp.2013.06.1298.Peer-Reviewed Original Research
2009
Radiotherapy for patients with the human immunodeficiency virus: Are special precautions necessary?
Housri N, Yarchoan R, Kaushal A. Radiotherapy for patients with the human immunodeficiency virus: Are special precautions necessary? Cancer 2009, 116: 273-283. PMID: 20014399, PMCID: PMC3409663, DOI: 10.1002/cncr.24878.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusAntiretroviral therapyImmunodeficiency virusInteraction of HIVImmunodeficiency syndrome (AIDS) epidemicRadiation-associated toxicitiesCourse of radiotherapyManagement of malignanciesHIV patientsMajority of reportsKaposi's sarcomaPatientsRadiotherapyMedical literatureMalignancyAIDSTherapyVirusToxicityReportSpecial precautionsChemoradiotherapySarcomaCancerTumor Nodule Location Predicts the Feasibility of Intraprostatic High-dose Irradiation in Men with Localized Prostate Cancer
Housri N, Ondos J, Choyke P, Barbara A, Ning H, Citrin D, Singh A, Kaushal A. Tumor Nodule Location Predicts the Feasibility of Intraprostatic High-dose Irradiation in Men with Localized Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s143-s144. DOI: 10.1016/j.ijrobp.2009.07.340.Peer-Reviewed Original Research